This focused issue on “Muscle-invasive Bladder Cancer” is edited by Dr. Ja Hyeon Ku, from Department of Urology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea; Dr. Ho Kyung Seo, from Center for Prostate Cancer, National Cancer Center, Goyang, Gyeonggi, Korea; and Dr. Seok Ho Kang, from Department of Urology, Korea University College of Medicine, Seoul, Korea.
Dr. Ja Hyeon Ku graduated from Soonchunhyang University School of Medicine (Seoul, South Korea) in 1995. He was trained as a Urology Residency at Soonchunhyang University Hospital from 1996 to 2000, and finally acquired the urology board in 2000. He further completed Urology Fellowship at Seoul National University Hospital between 2003 and 2005. He obtained his PhD degree in Department of Urology at Seoul National University College of Medicine in 2005. His clinical and research interests and are primarily focused on urologic oncology, particularly urothelial carcinoma of upper urinary tract and urinary bladder. His area of clinical activities also includes other major urological cancer, including prostate cancer and kidney cancer.
Dr. Ho Kyung Seo currently works in Department of Urology, Center for Prostate Cancer, National Cancer Center, Goyang, Korea. He obtained his M.D. and PhD from Busan National University College of Medicine in 1994 and 2006. Dr. Seo is the member of Korean Urological Association and Korean Urologic Oncology Society.
Dr. Seok Ho Kang currently is Professor of Department of Urology, Korea University College of Medicine, Seoul, Korea.
Focused issue outline:
1. Muscle-invasive bladder cancer
Ja Hyeon Ku, Department of Urology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
2. Oncological and functional outcomes of robot-assisted radical cystectomy
Nikhil Vasdev, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK
3. Sentinel node biopsy in muscle-invasive bladder cancer
Ashok K. Hemal, Department of Urology, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA
4. Is there a oncological benefit of an extended lymphadenectomy in muscle-invasive bladder cancer?
Alvin Goh, Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA
5. The role of surgery in clinical node positive muscle-invasive bladder cancer
Dong Hyeon Lee, Department of Urology, Ewha Womans University School of Medicine, Seoul, Korea
6. The optimal management of variant histology in muscle-invasive bladder cancer
Lee Lui Shiong, Department of Urology, Singapore General Hospital, Republic of Singapore
7. Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer
Wassim Kassouf, Department of Surgery, McGill University Health Center, McGill University, Montreal, Canada
8. The role of MRI in staging of bladder cancer
Deuk Jae Sung, Department of Radiology, Korea University Anam Hospital, Inchon-ro, Seongbuk-gu , Seoul , Republic of Korea
9. What is a role of PET/CT in muscle-invasive bladder cancer management
Seok-ki Kim, Department of Nuclear Medicine, National Cancer Center, Goyang, Korea
10. Enhanced recovery after surgery (ERAS) for radical cystectomy
Hyeong Dong Yuk, Department of Urology, Seoul National University College of Medicine, Seoul, Korea
11. Health-related quality of life after radical cystectomy
Bum Sik Tae, Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea
12. Perioperative systemic immunotherapy in muscle-invasive bladder cancer
Hyo Jin Lee, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
13. Clinical implication of molecular subtypes of muslce-invasive bladder cancer for neoadjuvant chemotherapy
Woonyoung Choi, Johns Hopkins School of Medicine, Baltimore, MD, USA
14. Tumor heterogeneity in muscle-invasive bladder cancer
Seok Joong Yun, Department of Urology, Chungbuk National University, College of Medicine, Cheongju, Korea
The focused issue “Muscle-invasive Bladder Cancer” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Ja Hyeon Ku, Ho Kyung Seo and Seok Ho Kang are serving as the unpaid Guest Editors for the focused issue.